CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
38.77
+1.05 (2.78%)
Sep 18, 2025, 12:04 PM EDT - Market open

CG Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
2,9562,183---
Enterprise Value
2,3171,643---
Last Close Price
37.7228.68---
PS Ratio
5403.751916.94---
PB Ratio
4.292.98---
P/TBV Ratio
4.442.98---
EV/Sales Ratio
4205.831442.48---
Debt / Equity Ratio
0.0000.000.130.38
Asset Turnover
-0.000.000.00-
Quick Ratio
21.7834.7613.179.328.97
Current Ratio
22.1535.3013.629.549.78
Return on Equity (ROE)
--19.18%-31.36%-42.85%-
Return on Assets (ROA)
--15.02%-19.97%-21.34%-
Return on Capital (ROIC)
--15.60%-21.24%-22.42%-
Earnings Yield
-4.30%-4.03%---
FCF Yield
-3.16%-3.62%---
Buyback Yield / Dilution
-376.91%-1343.03%-15.77%-2.48%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q